Entourage Health Announces $8.9 Million Upsize to Credit Facility and Implementation of Proposed Amendments to 8.5% Unsecured Convertible Debentures
June 27, 2022 11:15 ET
|
Entourage Health Corp.
TORONTO, June 27, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis...
Entourage Health Announces Debentureholders Overwhelmingly Approve Proposed Amendments to 8.5% Unsecured Convertible Debentures
June 20, 2022 13:21 ET
|
Entourage Health Corp.
TORONTO, June 20, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis...
Entourage Announces Results of 2022 Annual General Meeting of Shareholders
June 15, 2022 10:40 ET
|
Entourage Health Corp.
TORONTO, June 15, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis...
Entourage Health Extends its Senior Secured Credit Facility Maturity Date
June 01, 2022 08:03 ET
|
Entourage Health Corp.
TORONTO, June 01, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis...
Entourage Health Reports Record First Quarter 2022 Financial Results
May 30, 2022 18:35 ET
|
Entourage Health Corp.
Gross revenue* of $17.4 million, up 28% sequentially and 37% year over year Total revenue of $15.8 million in Q1, 2022 represents a 17% sequential increase over Q4 2021Gross Profit Before Fair Value...
Entourage Health Announces Canadian Debut of The Boston Beer Company’s New Cannabis-Infused Iced Tea Beverages ‘TeaPot’
May 24, 2022 07:40 ET
|
Entourage Health Corp.
TORONTO, May 24, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis...
Entourage Health Reaffirms First Quarter 2022 Preliminary Record Revenues of $17.4 Million and Announces Financial Results Call to be held on May 31, 2022
May 20, 2022 07:30 ET
|
Entourage Health Corp.
TORONTO, May 20, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis...
Entourage Health Enters into Voting Support Agreement and Announces Proposed Amendments to its 8.5% Unsecured Convertible Debentures
May 13, 2022 08:22 ET
|
Entourage Health Corp.
TORONTO, May 13, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of...
Entourage Health to Present at the Canaccord Genuity 6th Annual Global Cannabis Virtual Conference on May 11th
May 10, 2022 11:36 ET
|
Entourage Health Corp.
TORONTO, May 10, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of...
Entourage Reports Record Fiscal Year 2021 Financial Results with $55.2 Million in Total Revenue for a 56% Year-Over-Year Increase and Preliminary Q1 2022 Record Revenue of $17.4 Million
May 09, 2022 10:49 ET
|
Entourage Health Corp.
Net revenue increased to $42.2 million for the full year ended December 31, 2021 Preliminary unaudited Q1 2022 total revenue $17.4 million(1) representing 35% YOY growthUpsized credit facility with...